Podcast

Episode 46: Strategy in the Life Sciences

Listen on:

   

Featured

Frazis Capital Partners
06/06/2021
SALT interview with Rachel Pether

SALT interview with Rachel Pether

Hello all, I recorded the interview above with Rachel Pether from SALT (the alternative investment conference/forum founded by Anthony Scaramucci).

Michael Frazis

Portfolio Manager, Managing Partner

This Weeks Guest.

Robert Stretch, MD

 

New Episodes Weekly

Live Every Thursday @ 9am

Timestamps
·      0:32 – Our fast-growing portfolio companies
·      2:21 – Frazis life sciences strategy update
·      5:18 – RNAi Biology
·      7:15 – Alnylam: RNAi clinical development pipeline and recent execution
·      8:16 – Timing and valuation in life sciences
·      9:26 – What do we think of CRISPER?
·      11:03 – Companies targeting sickle cell disease
·      11:56 – Companies targeting beta-thalassemia
·      12:53 – Platform technologies: Moderna
·      15:12 – Platform technologies: Ultragenyx
·      16:30 – Special focus: Alzheimer’s
·      18:50 –Alzheimer’s APOE4
·      23:50 – Could Alzheimer’s be caused by infection?
·      24:55 – Cortexyme: Alzheimer’s and the gingivalis hypothesis
·      27:00 – Cassava and Alzheimer’s
·      28:30 – How are we different to Ark?
·      29:10 – Summary

Signup for Frazis Insights

Get monthly shareouts from the Frazis team, keep up to date on perspectives, interviews, features, spaces and more.